Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Re-Importation Bill Impact Could Be Limited By Canadian Export Laws

Executive Summary

Canadian export regulations would limit the impact of pharmaceutical re-importation proposals pending in Congress, a former Canadian official said at a July 24 American Enterprise Institute conference in Washington, D.C.
Advertisement

Related Content

Canadian Rx Prices Are 14% Lower Than U.S., Merck-Funded Study Finds
Canadian Rx Prices Are 14% Lower Than U.S., Merck-Funded Study Finds
Pharmacies Should Have Same Right To Import As Manufacturers - NCPA
Clinton Medicare Rx Plan Would Give Program Pricing "Clout" - Families USA
FDA May Revise Import Notices; Bills Would Jeopardize Safety, Agency Says
FDA May Revise Import Notices; Bills Would Jeopardize Safety, Agency Says
Senate Re-Importation Bill Opposed By Wholesalers, Chains; NCPA Supports
Senate Re-Importation Bill Opposed By Wholesalers, Chains; NCPA Supports
Rx Importation Bills "Unlikely" To Become Law, Lilly Tells Investors
PCS "Encouraged" By Pricing Of COX-2 Inhibitors Close To Branded NSAIDs
Advertisement
UsernamePublicRestriction

Register

PS036442

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel